Answers are grounded in this paper and cite their sources.
Rabies remains one of the most important vaccine-preventable zoonoses, with domestic dogs serving as the principal source of human infection in most endemic settings. The cornerstone of dog-mediated rabies elimination is sustained mass dog vaccination sufficient to interrupt transmission, generally requiring vaccination of at least 70% of the dog population. In India, however, a substantial free-roaming dog population, variable ownership patterns, difficult terrain, limited manpower, dog-handling constraints and heterogeneous municipal and veterinary infrastructure make rapid achievement and maintenance of high vaccination coverage difficult. Oral rabies vaccination (ORV) offers a complementary approach for dogs that cannot be safely or efficiently captured for parenteral vaccination. Modern oral rabies vaccines and bait systems have undergone extensive development, with evidence from experimental studies and field trials in Asia, Africa and other regions demonstrating feasibility, acceptable oral vaccine uptake and induction of rabies-specific immune responses. Indian studies, particularly those conducted in Goa, have demonstrated that oral bait handout can access roaming dogs with fewer personnel than capture-vaccinate-release approaches and can be incorporated into large-scale vaccination operations. Nevertheless, ORV should not be regarded as a replacement for parenteral vaccination. Vaccine licensing, product availability, acceptance of the oral formulation, cold-chain and field logistics, monitoring of oral vaccine uptake, non-target exposure, public acceptance, cost, regulatory oversight and reliable vaccination coverage assessment remain important considerations. This review examines the scientific basis, operational justification, available evidence, opportunities, limitations and implementation prospects of ORV for free-roaming dogs in India. The evidence supports a phased, evidence-based and geographically targeted integration of ORV with existing parenteral mass dog vaccination and One Health rabies elimination programmes.
No takes yet. Share an insight, caveat, or question.
Udipta Bhuyan, Anindita Sandilya, Tolly Bora (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: